Liquid Biopsy Market 2021 Industry Emerging Trends, Top Players, Growth Insights Forecast To 2025

New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The global liquid biopsy market is expected to grow from $3.4 billion in 2020 to $3.87 billion in 2021 at a compound annual growth rate (CAGR) of 13.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The liquid biopsy market is expected to reach $7.57 billion in 2025 at a CAGR of 18%.

The Business Research Company offers "Liquid Biopsy Global Market Report 2021" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth and highlights important trends and strategies that players in the market can adopt.

Request for a Sample Copy of this report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

The liquid biopsy market consists of sales of liquid biopsy services and related products used to detect cancer at an early stage. Liquid biopsy is an easy and minimally invasive technology which involves test done on a blood sample to detect the DNA from tumour cells in the blood. Unlike surgical biopsies it allows medical doctors to find a tumour through a blood test.

Some of the key players involved in the liquid biopsy market are QIAGEN N.V., Roche Diagnostics, Bio-Rad Laboratories Inc., Myriad Genetics, Inc., Guardant Health Inc., Thermo Fisher Scientific, Guardant Health, Menarini Silicon Biosystems, Biocept, Inc. and F. Hoffmann-La Roche AG.

The countries covered in the global liquid biopsy market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global liquid biopsy market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Liquid Biopsy Market Segmentation:
1) By Product: Assays Kits, Instruments, Services
2) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers
3) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/liquid-biopsy-market-global-report

A Few Points From The Table Of Content
1. Executive Summary
2. Liquid Biopsy Market Characteristics
3. Liquid Biopsy Market Size And Growth
4. Liquid Biopsy Market Segmentation
5. Liquid Biopsy Market Regional And Country Analysis
……
26. Liquid Biopsy Market Competitive Landscape And Company Profiles
27. Key Mergers And Acquisitions In The Liquid Biopsy Market
28. Liquid Biopsy Market Trends And Strategies
29. Liquid Biopsy Market Future Outlook and Potential Analysis
30. Appendix

The report covers the trends and market dynamics of the liquid biopsy market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2815

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow our blog: http://blog.tbrc.info/

About The Business Research Company:
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

This release was published on openPR.